Laurus Labs Limited vs Sunil Healthcare Ltd

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Sunil Healthcare Ltd (SUNILSYNCHEMLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Laurus Labs Limited leads LAURUSLABS vs SUNILSYNCHEMLTD on 12 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth20
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
18.10
19.74
P/B ratio
1.37
0.10%
Dividend yield
0.00%
₹16.47
EPS
₹3.91

Profitability

LAURUSLABS takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
6.01%
17.58%
Return on capital
6.52%
26.09%
EBITDA margin
14.56%
13.07%
Net margin
4.57%

Growth

LAURUSLABS takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
-7.40%
3.91%
Profit CAGR (3Y)
-15.64%

Size & financial health

LAURUSLABS takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹69 Cr
₹6,813 Cr
Revenue
₹88 Cr
₹890 Cr
Net profit
₹4 Cr
0.45
Debt / equity
0.80
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 20.99 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Sunil Healthcare Ltd
  • + ["Stock is trading at 1.00 times its book value"]
  • − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -0.65% over past five years.", "Company has a low return on equity of 0.59% over last 3 years.", "Company has high debtors of 188 days."]
Laurus Labs Limited full analysis Sunil Healthcare Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.